Search

Hutchison China MediTech Ltd ADR

Abierto

SectorSanidad

13.84 -3.22

Resumen

Variación precio

24h

Actual

Mínimo

13.86

Máximo

14.43

Métricas clave

By Trading Economics

Ingresos

-8.9M

-8M

Ventas

3.7M

139M

P/B

Media del Sector

136.6

56.432

Margen de beneficios

-5.724

Empleados

1,790

EBITDA

18M

4M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+16.25% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

462M

2.4B

Apertura anterior

17.06

Cierre anterior

13.84

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

111 / 339 Clasificación en Healthcare

Hutchison China MediTech Ltd ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 sept 2026, 23:52 UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

21 sept 2026, 23:51 UTC

News

BlackRock Inc. is trading modestly lower in after-market hours, following the launch of its customizable LifePath Solutions target date framework.

21 sept 2026, 23:50 UTC

News

Northrop Grumman Corp is trading modestly lower in after-market hours, retracing from a peak and positioned below its 20-day moving average.

21 sept 2026, 23:36 UTC

Correlated Moves
News

The USD/DKK is trading higher as the People's Bank of China maintained its one-year Loan Prime Rate at 3.00%, signaling stable monetary policy.

21 sept 2026, 23:31 UTC

News

Tapestry Inc is trading modestly higher in after-market hours, with a current market capitalization of $22.56 billion, following three consecutive lower closes.

21 sept 2026, 23:25 UTC

News

Pentair PLC declared a $0.27 quarterly dividend amid a class action lawsuit alleging securities fraud, with shares modestly lower in after-market trading.

21 sept 2026, 23:15 UTC

News

TransDigm Group Inc. announced its Extant Aerospace unit will acquire assets for approximately $240 million, driving the stock higher in after-market hours.

21 sept 2026, 23:15 UTC

News

Baidu Inc faces two class action lawsuits alleging securities fraud, contributing to a slight decline in after-market trading amid ongoing financial concerns.

21 sept 2026, 23:11 UTC

Social Media
News

Eli Lilly has started construction on a $6.5 billion facility in Houston to produce its GLP-1 receptor agonist, Foundayo, creating over 600 permanent jobs.

21 sept 2026, 23:11 UTC

Social Media
News

Intel Corp shares advanced during after-market hours, supported by a record-high Nasdaq close and favorable conditions from falling Treasury yields and oil prices.

21 sept 2026, 23:06 UTC

News

Weyerhaeuser Co announced a $1 million investment in Drayton Valley, Alberta, marking its first Thrive program initiative in Canada, with shares modestly higher in after-market trading.

21 sept 2026, 23:06 UTC

News
Correlated Moves

Coinbase Global Inc is launching an IPO allocation service for U.S. customers and ceasing sports wagering in Michigan, with shares trading higher in after-market hours.

21 sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by a broader cryptocurrency rally and increased interest from large holders amid positive regulatory developments.

21 sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by regulatory developments and increased interest from large holders amid a broader cryptocurrency rally.

21 sept 2026, 23:05 UTC

News

Biogen Inc. is trading slightly higher in after-market hours following approvals for at-home LEQEMBI in Japan and China and new Phase 3 data for EMPAVELI.

21 sept 2026, 23:02 UTC

News
Social Media

GameStop shares rose in after-hours trading as CEO Ryan Cohen disclosed the purchase of 1.15M shares for about $26.4 million, increasing his ownership to 40.5 million.

21 sept 2026, 23:02 UTC

News

Bitcoin is sharply higher today, reaching its highest level since January, amid a broader cryptocurrency rally and positive U.S.-China trade developments.

21 sept 2026, 23:02 UTC

News

Bitcoin surged today to its highest level since January, driven by positive U.S.-China trade developments and easing inflation concerns, despite an earlier pullback.

21 sept 2026, 23:01 UTC

News

Decline in after-market trading after CMS announces potential fee cuts.

21 sept 2026, 23:01 UTC

News

Thor Industries shares rose in after-market trading following Keystone RV's record sales at the Hershey RV Show, attributed to strong dealer preparation and customer interest.

21 sept 2026, 23:01 UTC

News

Salesforce Inc shares are advancing in after-market trading following director David Kirk's acquisition of 4.18k shares for approximately $999.5k.

21 sept 2026, 23:01 UTC

News
Social Media

Vicor Corporation raised its Q3 2026 growth guidance from nearly 10% to over 20%, driving a sharp rise in its share price during after-hours trading.

21 sept 2026, 23:01 UTC

News

General Motors Co's stock is higher in after-market trading following a $697.7 million contract modification awarded to GM Defense LLC by the U.S. Department of War.

21 sept 2026, 23:01 UTC

News

DICK'S Sporting Goods Inc faces class action lawsuits over alleged securities fraud, contributing to a modest decline in after-market trading following disappointing earnings.

21 sept 2026, 23:01 UTC

Macro News
Correlated Moves
News

The U.S. dollar is consolidating against the yen, currently around JPY156.50, with options worth $2.3 billion expiring today.

21 sept 2026, 23:00 UTC

News

Endava PLC's shares have declined sharply in after-market trading following the appointment of Conor McShane as Interim CFO amid an accounting investigation.

21 sept 2026, 22:51 UTC

News
Social Media

Robinhood Markets Inc's stock is trading lower after-hours, reversing from a high of $126.41 earlier in the session amid a recovering cryptocurrency market.

21 sept 2026, 22:01 UTC

News

In after-market trading, Gartner Inc. has moved higher following five consecutive lower daily closes, despite remaining below its 20-day moving average.

21 sept 2026, 21:01 UTC

News
Event

AnaptysBio reported Q2 net income of $183.88 million and EPS of $5.11, exceeding expectations, leading to a rise in after-market trading.

21 sept 2026, 20:12 UTC

News
Correlated Moves

NBT Bancorp Inc. is trading higher in after-market hours following the announcement of Kimberly A. Boynton's appointment to its Board of Directors, effective October 1, 2026.

Comparación entre iguales

Cambio de precio

Hutchison China MediTech Ltd ADR previsión

Precio Objetivo

By TipRanks

16.25% repunte

Estimación a 12 Meses

Media 16.833 USD  16.25%

Máximo 18.5 USD

Mínimo 14 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hutchison China MediTech Ltd ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

2

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

111 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.